Malignant peripheral nerve sheath tumor natural History, complications and prognosis: Difference between revisions
Shanshan Cen (talk | contribs) No edit summary |
Shanshan Cen (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{SC}} | {{CMG}}; {{AE}} {{SC}} | ||
==Overview== | ==Overview== | ||
==Complications== | |||
'''Metastasis''' | |||
* [[Metastasis]] occurs in about 39% of patients, most commonly to the lung. Features associated with poor prognosis include a large primary tumor (over 5 cm across), high [[grading (tumors)|grade]] disease, co-existent neurofibromatosis, and the presence of metastases.<ref name="pmid24174807">{{cite journal| author=Panigrahi S, Mishra SS, Das S, Dhir MK| title=Primary malignant peripheral nerve sheath tumor at unusual location. | journal=J Neurosci Rural Pract | year= 2013 | volume= 4 | issue= Suppl 1 | pages= S83-6 | pmid=24174807 | doi=10.4103/0976-3147.116480 | pmc=PMC3808069 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24174807 }} </ref> | |||
==Prognosis== | ==Prognosis== | ||
Prognosis of malignant peripheral nerve sheath tumor is generally poor. | |||
Patient response to treatment will vary based on age, health, and the tolerance to medications and therapies. | Patient response to treatment will vary based on age, health, and the tolerance to medications and therapies. | ||
It is a rare tumor type, with a relatively poor prognosis in children.<ref name="pmid12632346">{{cite journal |author=Neville H, Corpron C, Blakely ML, Andrassy R |title=Pediatric neurofibrosarcoma |journal=J. Pediatr. Surg. |volume=38 |issue=3 |pages=343–6; discussion 343–6 |year=2003 |pmid=12632346 |doi=10.1053/jpsu.2003.50105}}</ref> | It is a rare tumor type, with a relatively poor prognosis in children.<ref name="pmid12632346">{{cite journal |author=Neville H, Corpron C, Blakely ML, Andrassy R |title=Pediatric neurofibrosarcoma |journal=J. Pediatr. Surg. |volume=38 |issue=3 |pages=343–6; discussion 343–6 |year=2003 |pmid=12632346 |doi=10.1053/jpsu.2003.50105}}</ref> | ||
Line 12: | Line 17: | ||
In addition, MPNSTs are extremely threatening in NF1. In a 10-year institutional review for the treatment of chemotherapy for MPNST in NF1, which followed the cases of 1 per 2,500 in 3,300 live births, chemotherapy did not seem to reduce mortality, and its effectiveness should be questioned. Although with recent approaches with the molecular biology of MPNSTs, new therapies and prognostic factors are being examined. | In addition, MPNSTs are extremely threatening in NF1. In a 10-year institutional review for the treatment of chemotherapy for MPNST in NF1, which followed the cases of 1 per 2,500 in 3,300 live births, chemotherapy did not seem to reduce mortality, and its effectiveness should be questioned. Although with recent approaches with the molecular biology of MPNSTs, new therapies and prognostic factors are being examined. | ||
<ref>{{cite journal|last=Zehou|first=Ouidad|title=Chemotherapy For The Treatment Of Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis 1: A 10-Year Institutional Review.|journal=Orphanet Journal Of Rare Diseases|date=2013|volume=8|issue=1|page=1|accessdate=7 Apr 2014}}</ref> | <ref>{{cite journal|last=Zehou|first=Ouidad|title=Chemotherapy For The Treatment Of Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis 1: A 10-Year Institutional Review.|journal=Orphanet Journal Of Rare Diseases|date=2013|volume=8|issue=1|page=1|accessdate=7 Apr 2014}}</ref> | ||
==References== | ==References== |
Revision as of 18:39, 4 December 2015
Malignant peripheral nerve sheath tumor Microchapters |
Differentiating Malignant Peripheral Nerve Sheath Tumor from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Malignant peripheral nerve sheath tumor natural History, complications and prognosis On the Web |
American Roentgen Ray Society Images of Malignant peripheral nerve sheath tumor natural History, complications and prognosis |
FDA on Malignant peripheral nerve sheath tumor natural History, complications and prognosis |
CDC on Malignant peripheral nerve sheath tumor natural History, complications and prognosis |
Malignant peripheral nerve sheath tumor natural History, complications and prognosis in the news |
Blogs on Malignant peripheral nerve sheath tumor natural History, complications and prognosis |
Directions to Hospitals Treating Malignant peripheral nerve sheath tumor |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
Complications
Metastasis
- Metastasis occurs in about 39% of patients, most commonly to the lung. Features associated with poor prognosis include a large primary tumor (over 5 cm across), high grade disease, co-existent neurofibromatosis, and the presence of metastases.[1]
Prognosis
Prognosis of malignant peripheral nerve sheath tumor is generally poor. Patient response to treatment will vary based on age, health, and the tolerance to medications and therapies.
It is a rare tumor type, with a relatively poor prognosis in children.[2]
In addition, MPNSTs are extremely threatening in NF1. In a 10-year institutional review for the treatment of chemotherapy for MPNST in NF1, which followed the cases of 1 per 2,500 in 3,300 live births, chemotherapy did not seem to reduce mortality, and its effectiveness should be questioned. Although with recent approaches with the molecular biology of MPNSTs, new therapies and prognostic factors are being examined. [3]
References
- ↑ Panigrahi S, Mishra SS, Das S, Dhir MK (2013). "Primary malignant peripheral nerve sheath tumor at unusual location". J Neurosci Rural Pract. 4 (Suppl 1): S83–6. doi:10.4103/0976-3147.116480. PMC 3808069. PMID 24174807.
- ↑ Neville H, Corpron C, Blakely ML, Andrassy R (2003). "Pediatric neurofibrosarcoma". J. Pediatr. Surg. 38 (3): 343–6, discussion 343–6. doi:10.1053/jpsu.2003.50105. PMID 12632346.
- ↑ Zehou, Ouidad (2013). "Chemotherapy For The Treatment Of Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis 1: A 10-Year Institutional Review". Orphanet Journal Of Rare Diseases. 8 (1): 1.
|access-date=
requires|url=
(help)